πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· INN Directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed
4,797
Companies
1,769
Pipeline programs
20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Showing page 181 of 200 Β· A–Z by INN

  1. testolactone

    TESLAC

    INJECTION FDA: approved

  2. testosterone

    ANDROFORTE 5 Lacuna Pharma Pty Ltd

    IMPLANTATION FDA: approved Β· EMA: withdrawn Β· TGA: approved

    G03BA03
  3. testosterone cypionate

    TESTOSTERONE CYPIONATE Regeneron Ireland Designated Activity Company (DAC)

    INTRAMUSCULAR FDA: approved

  4. testosterone enanthate

    TESTOSTERONE ENANTHATE

    INJECTION FDA: approved

  5. testosterone propionate

    TESTOSTERONE PROPIONATE

    INJECTION FDA: approved

  6. testosterone undecanoate

    GONADRON Lacuna Pharma Pty Ltd

    INTRAMUSCULAR FDA: approved Β· TGA: approved

  7. tetrabenazine

    INOVA PHARMACEUTICALS (AUSTRALIA) PTY LTD Lacuna Pharma Pty Ltd

    ORAL FDA: approved Β· TGA: approved

  8. tetracaine hydrochloride

    TETRACAINE HYDROCHLORIDE

    OPHTHALMIC FDA: approved

  9. tetracaine hydrochloride gel

    NMPA: clinical trials

  10. tetracosactide

    SYNACTHEN DEPOT 1 MG/1 ML

    TGA: approved

  11. tetracycline hydrochloride

    TETRACYN Amneal Pharma Europe Ltd

    TOPICAL FDA: approved

  12. tetracycline phosphate complex

    TETREX

    ORAL FDA: approved

  13. tetrahydrozoline hydrochloride

    TYZINE

    NASAL FDA: approved

  14. tezacaftor

    SYMKEVI Vertex Pharmaceuticals (Australia) Pty.

    EMA: approved

    R07AX31
  15. tezepelumab

    TEZSPIRE

    EMA: approved

    R03DX11
  16. tezepelumab-ekko

    TEZSPIRE

    SUBCUTANEOUS FDA: approved

  17. tg103

    NMPA: clinical trials

  18. tg103 15 mg

    NMPA: clinical trials

  19. tg103 22.5 mg

    NMPA: clinical trials

  20. tg103 7.5 mg

    NMPA: clinical trials

  21. thalidomide

    THALOMID Bristol-Myers Squibb Australia Pty Ltd

    ORAL FDA: approved Β· EMA: approved Β· TGA: approved Β· PMDA: approved Β· NMPA: clinical trials

    L04AX02
  22. thallous chloride tl-201

    THALLOUS CHLORIDE TL 201

    INJECTION FDA: approved

  23. theophylline

    NUELIN Lacuna Pharma Pty Ltd

    INJECTION FDA: approved Β· TGA: approved

  24. theophylline sodium glycinate

    ASBRON

    ORAL FDA: approved

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles β€” INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page β€” it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Data attribution and licensing: Data sources